Minimal Stent Area: New IVUS Parameter?

Intravascular Ultrasound (IVUS) has shown, in several studies, its great benefits for both restenosis and mortality reduction.  

Área mínima del stent ¿es un nuevo parámetro para tener en cuenta en el IVUS?

Even though several variables have been studied, so far minimal stent area (MSA) has been disregarded as important. 

The OPTIVUS-Complex PCI looked at 961 patients with 1,957 lesions, and found 1.6% TLR incidence (30 lesions).

There were no significant differences between patients presenting TLR and those who did, except for a higher incidence of hemodialysis in the second group. 

As regards the procedure, there were no differences in pre and post dilation, lesion complexity, chronic occlusions, vessel diameter, QCA, lesion length, or proximal reference area. 

Time from PCI to TLR was 251 days (167-325), and 73% happened after 180 days. 

Read also: Association Between Radial Wall Strain (RWS) and Risk of Acute Myocardial Infarction.

66.7% of TLR was ischemia driven. 

Even though hemodialysis and MSA were more frequent in TLR patients, the difference did not reach statistical significance. 

Conclusion

At present, TLR incidence after IVUS guided PCI at one year is quite low. Minimal stent area, but not other stent expansion criteria, has been associated with TLR upon multivariable analysis. Independent factors were calcified lesions and small proximal reference lumen area. Therefore, these findings should be interpreted with caution, seeing the low number of TLR events, the limited number of complex lesions and the short followup. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention.

Reference: Yamamoto, et al. Circ Cardiovasc Interv.2023;16:e012922.DOI:10.1161/CIRCINTERVENTIONS.123.012922.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....